ESC 365 - MicroRNA assessment in secondary mitral regurgitation - evidence for remodelling mechanisms at a cellular level

Back

HFA Premium Access

MicroRNA assessment in secondary mitral regurgitation - evidence for remodelling mechanisms at a cellular level

Session: Valvular Heart Disease and Interventional Cardiology

Topic: Mitral Valve Regurgitation

Speaker: Doctor G. Spinka (Vienna, AT)

Event: Heart Failure 2021

Congress Presentation

Add to my library

About the speaker

Doctor Georg Spinka

Medical University of Vienna, Vienna (Austria)

0 follower

8 more presentations in this session

2-year outcomes for transcatheter repair in patients with functional mitral regurgitation from the CLASP study

Speaker: Doctor P. Kourkoveli (Maroussi-Athens, GR)

Impact of mitral regurgitation in patients with worsening heart failure: Insights from BIOSTAT-CHF.

Speaker: Doctor M. Pagnesi (Brescia, IT)

Prevalence and determinants of right ventricular dysfunction in patients with severe symptomatic high-gradient aortic stenosis

Speaker: Doctor S. Maltes (Lisbon, PT)

Gender disparities in percutaneous mitral valve repair

Speaker: Professor I. Oh (Pforzheim, DE)

Chronic kidney disease impact after mitraclip therapy: five-year outcomes from the GRASP registry

Speaker: Doctor M. Pelliccia (Tivoli, IT)

Access the full session

Valvular Heart Disease and Interventional Cardiology

Speakers: Doctor G. Spinka, Doctor P. Kourkoveli, Doctor M. Pagnesi, Doctor S. Maltes, Professor I. Oh...

Access

About the event

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources